<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(7)</volume><submitter>Jager D</submitter><funding>Dietmar-Hopp Foundation</funding><journal>Clinical and translational medicine</journal><pagination>e1776</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11260171</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Novel chimeric antigen receptors for the effective and safe treatment of NY-BR-1 positive breast cancer.</pubmed_title><pmcid>PMC11260171</pmcid><pubmed_authors>Berger A</pubmed_authors><pubmed_authors>Aulmann S</pubmed_authors><pubmed_authors>Fremd C</pubmed_authors><pubmed_authors>Jager D</pubmed_authors><pubmed_authors>Lichter P</pubmed_authors><pubmed_authors>Tuch A</pubmed_authors><pubmed_authors>Heussel CP</pubmed_authors><pubmed_authors>Eurich R</pubmed_authors><pubmed_authors>Schmidt P</pubmed_authors><pubmed_authors>Luckner-Minden C</pubmed_authors><pubmed_authors>Harbottle R</pubmed_authors><pubmed_authors>Hlevnjak M</pubmed_authors><pubmed_authors>Zornig I</pubmed_authors><pubmed_authors>Schneeweiss A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Novel chimeric antigen receptors for the effective and safe treatment of NY-BR-1 positive breast cancer.</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2025-04-26T22:17:10.024Z</modification><creation>2025-04-06T17:12:02.172Z</creation></dates><accession>S-EPMC11260171</accession><cross_references><pubmed>39032146</pubmed><doi>10.1002/ctm2.1776</doi></cross_references></HashMap>